BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2019; 7(21): 3622-3631
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3622
Child with Wiskott–Aldrich syndrome underwent atypical immune reconstruction after umbilical cord blood transplantation: A case report
Shao-Yan Hu, Bo-Han Li
Bo-Han Li, Shao-Yan Hu, Department of Hematology and Oncology, Children’s Hospital of Soochow University, Suzhou 215000, Jiangsu Province, China
Author contributions: Li BH and Hu SY wrote and edited the final manuscript; both authors have read and approved the final manuscript.
Supported by National Natural Science Foundation of China, No. 81770193.
Informed consent statement: Written informed consent was obtained from the patient’s legal guardian(s) for publication of this case report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest in relation to this manuscript.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Shao-Yan Hu, PhD, Chief Doctor, Department of Hematology and Oncology, Children’s Hospital of Soochow University, 92 Zhongnan Street, Suzhou 215000, Jiangsu Province, China. hsy139@126.com
Telephone: +86-512-80692929
Received: April 17, 2019
Peer-review started: April 18, 2019
First decision: June 12, 2019
Revised: June 21, 2019
Accepted: July 20, 2019
Article in press: July 20, 2019
Published online: November 6, 2019
Processing time: 206 Days and 0.2 Hours
Core Tip

Core tip: The timely reconstitution of a donor-derived immune system is of utmost importance for the recovery and long-term survival of patients after hematopoietic stem cell transplantation. Here, we describe a case of Wiskott–Aldrich syndrome treated by umbilical cord blood transplantation with the atypical process of immune reconstitution. Our case revealed that an increase in the number of lymphocytes (especially T cells) earlier than granulocytes may be a marker of a good prognosis in patients. This experience will guide clinical scientists, especially hematologists, to deal with similar situations and encourage them to identify more processes that require immune reconstruction.

Write to the Help Desk